Table 4.
Variables | Early LNB (all patients) |
Cranial neuropathies* | Encephalitis* | Myelitis* | Late LNB |
---|---|---|---|---|---|
Pleocytosis, cellsx106/l, median (IQR); min–max; N | 112 (57.75–238.25); 12–867; N = 100 |
117 (69–260.75); 19–867; N = 56 |
400 (93–589); 45–613; N = 9 |
682.50 (592–0); 592–973; N = 2 |
230; 135–305; N = 3 |
Lymphocytes %, median (IQR); min–max; N | 97.5 (92–100); (10–100); N = 98 |
97 (90–100); 10–100; N = 55 |
98 (80.50–100); 65–100; N = 5 | 51 (10–92); N = 2 | 90; 21–97; N = 3 |
Protein, g/l, median (IQR); min–max; N | 1.10 (0.70–1.65); 0.33–6.09 | 1.23 (0.71–1.69); 0.36–6.09; N = 56 | 1.3 (0.84–4.29); 0.70–6.09; N = 9 | 3.41; 1.05–5.77; N = 2 | 3.3; 1.8–6.47; N = 3 |
Glucose, mmol/l, median (IQR); min–max; N |
3.04 (2.60–3.44); 0.40–5.50 |
3 (2.58–3.50); 0.4–4.38; N = 55 |
2.9 (2.21–3.73); 1.60–5.50; N = 9 | 2.03; 0.4–3.65; N = 2 | 2.6; 1.88–3.1; N = 3 |
Intrathecal synthesis of B. burgdorferi s.l. N (%) | |||||
IgM | 60/95 (63.2) | 34/52 (65.4) | 4/9 (44.4) | 1/2 (50) | 1/3 (33.3) |
IgG | 79/98 (77.6) | 45/55 (81.8) | 8/9 (88.9) | 1/2 (50) | 3/3 (100) |
Either IgM or IgG, or both | 92/100 (92) | 52/56 (92.9) | 9/9 (100) | 2/2 (100) | 3/3 (100) |
*Patients with early LNB.
LNB Lyme neuroborreliosis, IQR interquartile range.
Normal values: protein (g/l) 0.15–0.45;